N2 supplement drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| N2 supplement | associated_with | DMEM/F12 | — | 1 |
Mentioned in (14)
Papers in which this entity is mentioned.
- Massively parallel reporter assay investigates shared genetic variants of eight psychiatric disorders. (2025)
- Synchronized long-read genome, methylome, epigenome and transcriptome profiling resolve a Mendelian condition. (2025)
- Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. (2018)
- Variations in brain defects result from cellular mosaicism in the activation of heat shock signalling. (2017)
- Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations. (2017)
- Sustained synchronized neuronal network activity in a human astrocyte co-culture system. (2016)
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes. (2016)
- Dose-dependent alcohol-induced alterations in chromatin structure persist beyond the window of exposure and correlate with fetal alcohol syndrome birth defects. (2015)
- Pilot study of iPS-derived neural cells to examine biologic effects of alcohol on human neurons in vitro. (2012)
- Alcohol alters DNA methylation patterns and inhibits neural stem cell differentiation. (2011)
- Retentive multipotency of adult dorsal root ganglia stem cells. (2009)
- Molecular mechanisms of Sonic hedgehog mutant effects in holoprosencephaly. (2005)
- In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. (2000)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| n2 supplement | drug | 14 | 23 |